DoD-Funded Stem Cell Trial Expands to Phase II for Traumatic Brain Injury
A new clinical trial in Texas will evaluate stem cell therapy’s potential to improve outcomes for adults with chronic TBI.
Neurology
Silk Based Nerve Repair Technology begins Trials
The first use of silk-based SilkAxons™ aims to address large peripheral nerve injuries where current treatments fall short.
NurExone Granted U.S. Patent for Exosome Manufacturing Process, Enhancing Supply Chain Capabilities
NurExone secures U.S. patent protection for its exosome production method, supporting scale-up and clinical supply chain readiness.
Hope Biosciences Awarded FDA RMAT Designation for Multiple Sclerosis Stem Cell Therapy
The FDA designation follows promising Phase II trial results for Hope Biosciences’ stem cell therapy in relapsing-remitting multiple sclerosis.
Regenerative Spinal Cord Therapy: Interview with Nurexone Biologic’s CEO, Dr. Lior Shaltiel
Nurexone Biologic has developed an exosome therapy for nerve repair, we interviewed the CEO, Dr. Lior Shaltiel here. Enjoy!
NurExone’s Exosomes Outperform Commercial Standard in Regenerative Study
Independent analysis finds NurExone’s exosomes deliver enhanced regenerative signals, showing promise for nerve repair and tissue healing applications.
Capricor Therapeutics Announces FDA Type A Meeting to Discuss Duchenne Muscular Dystrophy Treatment Path
Capricor Therapeutics is coordinating with the FDA on regulatory steps for its Duchenne therapy, with updates expected soon.
Sumitomo Pharma Submits Application for Japanese Approval of Stem Cell Therapy to Enhance Motor Function in Parkinson’s Disease
Sumitomo Pharma and RACTHERA seek approval for a novel iPS cell-based therapy targeting motor symptoms in advanced Parkinson’s.
Trailhead Biosystems Launches New iPSC-Derived Neurons for Parkinson’s Research
The iPSC-derived A9 dopaminergic neurons will hopefully offer researchers a human-based model for Parkinson’s disease studies.
New Trial: Umbilical Cord Stem Cell-Derived Exosome Nasal Drops for Neurodegenerative Diseases
Researchers will test whether nasal drops containing stem cell-derived vesicles can safely benefit people with a range of neurodegenerative diseases.
